The website of the Clinical Services Journal

RCS partners with NHS England to evaluate cancer treatments and strengthen services

A new national centre of excellence to strengthen NHS cancer services by looking at treatments and patient outcomes right across the country will be established at the Royal College of Surgeons of England (RCS England).

The National Cancer Audit Collaborating Centre will deliver five new national cancer audits in breast cancer (primary and metastatic), ovarian, pancreatic, non-Hodgkin lymphoma and kidney cancer. The new ‘centre’ is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England and the Welsh Government.

The collaborating centre will become part of the Clinical Effectiveness Unit (CEU) at RCS England, a collaboration between the College and the London School of Hygiene & Tropical Medicine. The CEU currently delivers clinical audits in prostate, lung, bowel, oesophageal and stomach cancer, and recently completed an audit of breast cancer in older patients. These audits have helped provide a wider understanding of cancer treatments across England and Wales, and improve outcomes for patients. They have also promoted improvement initiatives within NHS cancer services and identified areas of best practice.

NHS England and the Welsh Government will fund the five new clinical cancer audits, with £5.4m for an initial period of three years.  The aim of these audits will be to:

  1. Provide regular and timely evidence to cancer services of where patterns of care in England and Wales may vary. 
  2. Support NHS services to increase the consistency of access to treatments and help guide quality improvement initiatives.
  3. Stimulate improvements in cancer detection, treatment and outcomes for patients, including survival rates.

Professor Neil Mortensen, President of the Royal College of Surgeons of England said: “Over the past 15 years, our national clinical audits have shone an important spotlight on NHS cancer care across England and Wales, helping NHS hospitals to improve their services for patients.

“The announcement is fantastic news, complementing the national audits we already carry out in prostate, lung, breast, bowel, oesophageal and stomach cancer. It will provide more clinicians with the evidence base they need to review the care they are providing to patients, including those undergoing treatment for breast, ovarian, pancreatic, non-Hodgkin Lymphoma and kidney cancer. It will also help them to ensure they are following best clinical practice. The new centre will give surgeons and other clinicians an opportunity to gain invaluable experience of research and quality improvement projects.”

NHS England’s national cancer director, Dame Cally Palmer said: “These new clinical audits will play an important role in widening our understanding of the treatment that cancer patients receive from the NHS and will allow us to achieve more consistent outcomes for people across the country. Cancer diagnosis and treatment remains a top priority for the NHS, and our collaboration with the Royal College of Surgeons of England reaffirms our commitment to providing people with the very best cancer care.”

The National Cancer Audit Collaborating Centre will collaborate closely with professional groups and patient charities. Patient forums will be established to ensure that patients inform the quality improvement goals of each audit. The audits are committed to engaging widely with charities and experts involved in cancer care, delivering for patients and their families, as well as healthcare professionals and the health service.

Cancer treatment is complex – there are multiple treatment options for different types of cancer. A patient’s treatment plan needs to take into account the stage of their cancer and how they will respond to treatment.  A key aim for each audit will be to ensure the information produced for cancer services recognises these differences and supports hospitals to focus on specific parts of the care pathway.  

Dr Julie Nossiter, Director of Operations, National Cancer Audit Collaborating Centre said: “Each audit will be led by a multidisciplinary team of clinical experts and senior academics. This will ensure the new audits are produced to the same high standard as those that the Clinical Effectiveness Unit (CEU) has run for years, maintaining the standards of excellence the CEU is renowned for.  By having all the audits within one centre, teams will learn from each other, benefit from efficiencies and share best practice.”

The centre will start work on 1 October 2022.

Upcoming Events

IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022

Bournemouth
17-19 October 2022

UKHCA Conference: Listen Up

Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022

MEDICA 2022

Dusseldorf Germany
14th November - 17th November

Future Surgery 2022

ExCel, London
15th - 16th November 2022

IDSc Annual Conference

The Eastside Rooms, Birmingham
29th - 30th November 2022

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022

Bournemouth
17-19 October 2022

UKHCA Conference: Listen Up

Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022

MEDICA 2022

Dusseldorf Germany
14th November - 17th November

Future Surgery 2022

ExCel, London
15th - 16th November 2022

IDSc Annual Conference

The Eastside Rooms, Birmingham
29th - 30th November 2022

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025